Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
Health & Biotech
Not covered: Cann Group on the hook for $3.6 million cybersecurity incident
News
Last Orders: Stocks climb again as the ASX issues more speeding tickets
Health & Biotech
Cann Group lowers guidance, makes acquisition; Zelira to get new boss
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cann Group gets hit by cyber attack, says it’s given a fraudster $3.6m
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Cann Group just bought some exclusive access to Europe’s biggest medicinal cannabis market
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Cannabis stocks are finishing 2020 on a high; Cann Group, Bod announce new European orders
Health & Biotech
Weed Week: All eyes on the TGA after key decision pushed back to December
News
Last Orders: What you might have missed on the ASX today
News
ASX Small Cap Lunch Wrap: Markets boom as Dow runs through 30,000 points
News
10 at 10: These ASX stocks are looking pristine this morning
News
ASX Small Cap Lunch Wrap: Who’s on target for their best month in 32 years?
Health & Biotech
